自2025年11月12日起,新西兰开始更快地提供其他地方批准的新药品。 New Zealand launches faster access to new medicines approved elsewhere, effective Nov. 12, 2025.

新西兰实施了一项新系统,在得到跨党派支持后,使其他国家能够更快地获得新批准的药品。 New Zealand has implemented a new system allowing faster access to newly approved medicines in other countries, following cross-party support. 这项改革旨在减少在向病人提供新治疗方面的延误,使新西兰的批准程序更密切地符合国际标准。 The change aims to reduce delays in bringing new treatments to patients, aligning New Zealand’s approval process more closely with international standards. 2025年11月12日生效的政策更新标志着该国对药品的监管方针发生了重大转变。 The policy update, effective November 12, 2025, marks a significant shift in the country’s regulatory approach to pharmaceuticals.